BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12,404 Cr | ₹16,493 Cr | ₹15,120 Cr | ₹20,742 Cr | ₹6,803 Cr |
What is the latest Total Non-Current Liabilities ratio of BIOCON ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12,404 Cr |
| Mar2025 | ₹16,493 Cr |
| Mar2024 | ₹15,120 Cr |
| Mar2023 | ₹20,742 Cr |
| Mar2022 | ₹6,803 Cr |
How is Total Non-Current Liabilities of BIOCON Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,404 Cr | -24.79 | |
| Mar2025 | ₹16,493 Cr | 9.08 | |
| Mar2024 | ₹15,120 Cr | -27.11 | |
| Mar2023 | ₹20,742 Cr | 204.91 | |
| Mar2022 | ₹6,803 Cr | - | |
Compare Total Non-Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹67,567.4 Cr | 0.1% | -4.9% | 12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | 0.1% |
-4.9% |
12.6% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses